Early-life alcohol intake may increase prostate cancer risk

Image
IANS New York
Last Updated : Aug 23 2018 | 3:15 PM IST

Consuming at least seven drinks of alcohol per week in your adolescence may increase the risk of high grade prostate cancer later, a new study has found.

The study found that heavy alcohol intake at ages 15-19 was not associated with overall prostate cancer. However, consumption of at least seven drinks per week during this age increased 3.2 times the odds of high-grade prostate cancer.

"The prostate is an organ that grows rapidly during puberty, so it's potentially more susceptible to carcinogenic exposure during the adolescent years," said co-author Emma Allott, assistant professor at the University of North Carolinap.

"For this reason, we wanted to investigate if heavy alcohol consumption in early life was associated with the aggressiveness of prostate cancer later," Allott added.

For the study published in the Cancer Prevention Research, the research team evaluated data from 650 men undergoing a prostate biopsy between January 2007 and January 2018.

These veterans had no prior history of prostate cancer, and their ages ranged from 49 to 89 years old. The population was racially diverse -- 54 per cent of patients were non-white.

Men completed questionnaires which assessed the average number of alcoholic drinks consumed weekly during each decade of life to determine age-specific and cumulative lifetime alcohol intake.

Those who consumed at least seven alcoholic drinks per week at ages 20-29, 30-39, and 40-49, resulted in 3.14, 3.09, and 3.64 times the odds of high-grade prostate cancer, respectively, when compared with non-drinkers.

However, the current alcohol consumption was not significantly associated with high-grade prostate cancer, the researchers said.

The team also evaluated the association between cumulative lifetime alcohol consumption and prostate cancer diagnosis.

Compared with men in the lowest tertile of lifetime alcohol intake, those in the upper tertile had 3.2 times the odds of being diagnosed with high-grade prostate cancer at biopsy, the team said.

--IANS

vc/ksk/sed

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Aug 23 2018 | 3:08 PM IST

Next Story